Article
SLAMF8, a potential novel immune checkpoint molecule, is associated with the prognosis of colorectal cancer
2022-11-07
Abstract excerpt
Recently, immune checkpoint inhibitors (ICIs) represented by programmed cell death 1(PD-1) monoclonal antibody (mAb) have revolutionized the treatment mode of malignant tumors, and have achieved long-lasting antitumor effects in a variety of solid tumors. However, this antitumor effect is limited to a small subset of specific colorectal cancer (CRC). Therefore, screening and identifying new immune checkpoint molec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0b1b1ebc-3992-5679-9925-7ea7d25e7e9f
- DOI
- 10.21203/rs.3.rs-2239673/v1
